A supporter of the ban points to FDA “safeguards” in place when the drug was approved. (AP video: Joseph B. Frederick) A maker of the widely used abortion pill mifepristone asked the Supreme Court to block an appellate court ruling that cut off mail-order access to the drug in what was the biggest jolt to abortion policy since the overturning of Roe v. Wade. (AP video produced: Joseph B.
Main Idea: The Supreme Court temporarily protected broad telehealth and mail access to the abortion pill mifepristone while it considers a challenge brought by Louisiana.
Key Points:
Louisiana’s lawsuit could keep abortion pill access in legal limbo, forcing patients and clinics to scramble and raising costs and delays.
The Supreme Court’s stay keeps telehealth and mail access open for now, helping patients get timely care without extra travel.
Rate how each entity in this article affected the American people.
Central court that restored broad access to mifepristone and issued the key temporary order.
Named justice who signed the order that temporarily restored access.
Federal agency whose mifepristone rules are challenged and whose approval/safeguards are discussed.
Named state official who filed the lawsuit and publicly attacked the FDA rules.
State whose lawsuit against the FDA is a central driver of the case.
Named anti-abortion advocacy group that responded to the ruling and continued the legal fight.
Named Wyoming abortion clinic directly affected by the telehealth access changes.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentNamed legal aid group quoted on the practical effect of the ruling.
Named clinic operator appearing in a photo and part of the telehealth/abortion access context.